The role of inflammatory and fibrogenic pathways in heart failure associated with aging

Heart Failure Reviews

Volumn 15, Issue 5, 2010, Pages 415-422

  Chen, Wei ^a   Frangogiannis, Nikolaos G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Fibroblast; Heart failure; Infarction; Inflammation; Remodeling

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN II; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR AB; REACTIVE OXYGEN METABOLITE; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; APOPTOSIS; CARDITIS; CELL DEATH; DIASTOLE; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; DRUG TARGETING; ELDERLY CARE; FIBROBLAST; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; INHIBITION KINETICS; MEDICAL RESEARCH; MESENCHYME CELL; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PREVALENCE; REVIEW; SCAR FORMATION; SIGNAL TRANSDUCTION; SYSTOLE; SYSTOLIC DYSFUNCTION; TISSUE REPAIR;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANGIOTENSIN II; FIBROBLASTS; FIBROSIS; HEART FAILURE, DIASTOLIC; HUMANS; INFLAMMATION; MUSCLE CELLS; PHAGOCYTES; REACTIVE OXYGEN SPECIES; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA; UNITED STATES; VENTRICULAR REMODELING;

EID: 77955709345     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-010-9161-y     Document Type: Review

References (73)

1. MA Chen 2009 Heart failure with preserved ejection fraction in older adults Am J Med 122 713 723 10.1016/j.amjmed.2009.01.038 19635270
2. S Thomas MW Rich 2007 Epidemiology, pathophysiology, and prognosis of heart failure in the elderly Clin Geriatr Med 23 1 10 10.1016/j.cger.2006.08.001 17126752
3. CJ DeFrances KA Cullen LJ Kozak 2007 National hospital discharge survey: 2005 annual summary with detailed diagnosis and procedure data Vital Health Stat 13 1 209
4. EG Lakatta D Levy 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease Circulation 107 346 354 10.1161/01.CIR.0000048893.62841.F7 12538439
5. DW Kitzman JM Gardin JS Gottdiener A Arnold R Boineau G Aurigemma EK Marino M Lyles M Cushman PL Enright 2001 Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS research group. Cardiovascular health study Am J Cardiol 87 413 419 10.1016/S0002- 9149(00)01393-X 1:STN:280:DC%2BD3M3gsV2msw%3D%3D 11179524
6. AL Dannenberg D Levy RJ Garrison 1989 Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study) Am J Cardiol 64 1066 1068 10.1016/0002-9149(89)90816-3 1:STN:280: DyaK3c%2Fltlamsw%3D%3D 2530879
7. EG Lakatta 2002 Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons Heart Fail Rev 7 29 49 10.1023/A:1013797722156 11790921
8. EG Lakatta M Wang SS Najjar 2009 Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels Med Clin North Am 93 583 604 10.1016/j.mcna.2009.02.008 1:CAS:528: DC%2BD1MXotFSqu78%3D 19427493 Table of Contents
9. EG Lakatta D Levy 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease Circulation 107 139 146 10.1161/01.CIR.0000048892.83521.58 12515756
10. A Orlandi M Marcellini LG Spagnoli 2000 Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits Arterioscler Thromb Vasc Biol 20 1123 1136 1:CAS:528:DC%2BD3cXjtV2hsb4%3D 10764683
11. P Anversa T Palackal EH Sonnenblick G Olivetti LG Meggs JM Capasso 1990 Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart Circ Res 67 871 885 1:STN:280:DyaK3M%2FgsVKktA%3D%3D 2145091
12. W Cheng K Reiss P Li MJ Chun J Kajstura G Olivetti P Anversa 1996 Aging does not affect the activation of the myocyte insulin-like growth factor-1 autocrine system after infarction and ventricular failure in Fischer 344 rats Circ Res 78 536 546 1:CAS:528:DyaK28XhvVynurw%3D 8635210
13. BS Burlew 2004 Diastolic dysfunction in the elderly - the interstitial issue Am J Geriatr Cardiol 13 29 38 10.1111/j.1076-7460.2004.00059.x 14724399
14. MD Cheitlin 2003 Cardiovascular physiology-changes with aging Am J Geriatr Cardiol 12 9 13 10.1111/j.1076-7460.2003.01751.x 12502909
15. CR Gazoti Debessa LB Mesiano Maifrino R Rodrigues de Souza 2001 Age related changes of the collagen network of the human heart Mech Ageing Dev 122 1049 1058 10.1016/S0047-6374(01)00238-X 1:CAS:528:DC%2BD3MXktVKktbY%3D 11389923
16. RR de Souza 2002 Aging of myocardial collagen Biogerontology 3 325 335 10.1023/A:1021312027486 12510171
17. M Eghbali M Eghbali TF Robinson S Seifter OO Blumenfeld 1989 Collagen accumulation in heart ventricles as a function of growth and aging Cardiovasc Res 23 723 729 10.1093/cvr/23.8.723 1:CAS:528:DyaL1MXltlWntrg%3D 2598224
18. A Orlandi A Francesconi M Marcellini A Ferlosio LG Spagnoli 2004 Role of ageing and coronary atherosclerosis in the development of cardiac fibrosis in the rabbit Cardiovasc Res 64 544 552 10.1016/j.cardiores.2004.07.024 1:CAS:528:DC%2BD2cXpslOqu70%3D 15537508
19. J Lin EF Lopez Y Jin H Van Remmen T Bauch HC Han ML Lindsey 2008 Age-related cardiac muscle sarcopenia: combining experimental and mathematical modeling to identify mechanisms Exp Gerontol 43 296 306 10.1016/j.exger.2007.12. 005 1:CAS:528:DC%2BD1cXjtleksrk%3D 18221848
20. DP Thomas SD Zimmerman TR Hansen DT Martin RJ McCormick 2000 Collagen gene expression in rat left ventricle: interactive effect of age and exercise training J Appl Physiol 89 1462 1468 1:CAS:528:DC%2BD3cXotlylur0%3D 11007583
21. Y Iwanaga T Aoyama Y Kihara Y Onozawa T Yoneda S Sasayama 2002 Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats J Am Coll Cardiol 39 1384 1391 10.1016/S0735-1097(02)01756-4 1:CAS:528:DC%2BD38XjsFait7w%3D 11955860
22. JS Janicki GL Brower 2002 The role of myocardial fibrillar collagen in ventricular remodeling and function J Card Fail 8 S319 S325 10.1054/jcaf.2002. 129260 1:CAS:528:DC%2BD3sXnvVaktA%3D%3D 12555139
23. CF Baicu JD Stroud VA Livesay E Hapke J Holder FG Spinale MR Zile 2003 Changes in extracellular collagen matrix alter myocardial systolic performance Am J Physiol Heart Circ Physiol 284 H122 H132 1:CAS:528:DC%2BD3sXmvFyqtQ%3D%3D 12485818
24. J Wang M Hoshijima J Lam Z Zhou A Jokiel ND Dalton K Hultenby P Ruiz-Lozano J Ross Jr K Tryggvason KR Chien 2006 Cardiomyopathy associated with microcirculation dysfunction in laminin alpha4 chain-deficient mice J Biol Chem 281 213 220 10.1074/jbc.M505061200 1:CAS:528:DC%2BD28Xht1elsw%3D%3D 16204254
25. CA Beltrami N Finato M Rocco GA Feruglio C Puricelli E Cigola F Quaini EH Sonnenblick G Olivetti P Anversa 1994 Structural basis of end-stage failure in ischemic cardiomyopathy in humans Circulation 89 151 163 1:STN:280: DyaK2c7gvFSjuw%3D%3D 8281642
26. R Khan R Sheppard 2006 Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia Immunology 118 10 24 10.1111/j.1365-2567.2006.02336.x 1:CAS:528:DC%2BD28XkslyisbY%3D 16630019
27. DF Dai LF Santana M Vermulst DM Tomazela MJ Emond MJ MacCoss K Gollahon GM Martin LA Loeb WC Ladiges PS Rabinovitch 2009 Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging Circulation 119 2789 2797 10.1161/CIRCULATIONAHA.108.822403 1:CAS:528:DC%2BD1MXmtlKhtbg%3D 19451351
28. N Basso R Cini A Pietrelli L Ferder NA Terragno F Inserra 2007 Protective effect of long-term angiotensin II inhibition Am J Physiol Heart Circ Physiol 293 H1351 H1358 10.1152/ajpheart.00393.2007 1:CAS:528:DC%2BD2sXhtVOqtr7L 17557916
29. A Benigni D Corna C Zoja A Sonzogni R Latini M Salio S Conti D Rottoli L Longaretti, et al. 2009 Disruption of the Ang II type 1 receptor promotes longevity in mice J Clin Invest 119 524 530 10.1172/JCI36703 1:CAS:528:DC%2BD1MXivF2kt7k%3D 19197138
30. S Billet S Bardin S Verp V Baudrie A Michaud S Conchon M Muffat-Joly B Escoubet E Souil, et al. 2007 Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice J Clin Invest 117 1914 1925 10.1172/JCI28764 1:CAS:528:DC%2BD2sXnvVans70%3D 17607364
31. M Sawada JC Carlson 1987 Changes in superoxide radical and lipid peroxide formation in the brain, heart and liver during the lifetime of the rat Mech Ageing Dev 41 125 137 10.1016/0047-6374(87)90057-1 1:CAS:528: DyaL1cXnt1Oltw%3D%3D 2828774
32. DA Siwik PJ Pagano WS Colucci 2001 Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts Am J Physiol Cell Physiol 280 C53 C60 1:CAS:528:DC%2BD3MXjtVWmtbk%3D 11121376
33. TH Cheng PY Cheng NL Shih IB Chen DL Wang JJ Chen 2003 Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts J Am Coll Cardiol 42 1845 1854 10.1016/j.jacc.2003. 06.010 1:CAS:528:DC%2BD3sXpvVGjsbs%3D 14642698
34. NG Frangogiannis 2004 Chemokines in the ischemic myocardium: from inflammation to fibrosis Inflamm Res 53 585 595 10.1007/s00011-004-1298-5 1:CAS:528:DC%2BD2cXhtVKlsLzF 15693606
35. NG Frangogiannis 2007 Chemokines in ischemia and reperfusion Thromb Haemost 97 738 747 1:CAS:528:DC%2BD2sXlvVGrt7k%3D 17479184
36. NG Frangogiannis O Dewald Y Xia G Ren S Haudek T Leucker D Kraemer G Taffet BJ Rollins ML Entman 2007 Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy Circulation 115 584 592 10.1161/CIRCULATIONAHA.106.646091 1:CAS:528: DC%2BD2sXhtVyisrY%3D 17283277
37. O Dewald P Zymek K Winkelmann A Koerting G Ren T Abou-Khamis LH Michael BJ Rollins ML Entman NG Frangogiannis 2005 CCL2/Monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts Circ Res 96 881 889 10.1161/01.RES.0000163017.13772.3a 1:CAS:528:DC%2BD2MXjsFagsLw%3D 15774854
38. A Desmouliere A Geinoz F Gabbiani G Gabbiani 1993 Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts J Cell Biol 122 103 111 10.1083/jcb.122.1.103 1:CAS:528:DyaK3sXksVWrtLY%3D 8314838
39. M Bujak NG Frangogiannis 2007 The role of TGF-beta signaling in myocardial infarction and cardiac remodeling Cardiovasc Res 74 184 195 10.1016/j.cardiores.2006.10.002 1:CAS:528:DC%2BD2sXjvFehs7g%3D 17109837
40. WW Brooks CH Conrad 2000 Myocardial fibrosis in transforming growth factor beta(1)heterozygous mice J Mol Cell Cardiol 32 187 195 10.1006/jmcc.1999.1065 1:CAS:528:DC%2BD3cXhvVCgs7c%3D 10722796
41. MH Barcellos-Hoff TA Dix 1996 Redox-mediated activation of latent transforming growth factor-beta 1 Mol Endocrinol 10 1077 1083 10.1210/me.10.9.1077 1:CAS:528:DyaK28Xls1WhtrY%3D 8885242
42. SK Park J Kim Y Seomun J Choi DH Kim IO Han EH Lee SK Chung CK Joo 2001 Hydrogen peroxide is a novel inducer of connective tissue growth factor Biochem Biophys Res Commun 284 966 971 10.1006/bbrc.2001.5058 1:CAS:528: DC%2BD3MXktl2msbc%3D 11409888
43. AA Lee WH Dillmann AD McCulloch FJ Villarreal 1995 Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts J Mol Cell Cardiol 27 2347 2357 10.1016/S0022-2828(95)91983-X 1:CAS:528:DyaK2MXovFOhsLs%3D 8576949
44. SE Campbell LC Katwa 1997 Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts J Mol Cell Cardiol 29 1947 1958 10.1006/jmcc.1997.0435 1:CAS:528:DyaK2sXltVOqsrs%3D 9236148
45. K Saito N Ishizaka T Aizawa M Sata N Iso-o E Noiri I Mori M Ohno R Nagai 2005 Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart Am J Physiol Heart Circ Physiol 288 H1836 H1843 10.1152/ajpheart.00679.2004 1:CAS:528:DC%2BD2MXjtlOrur4%3D 15550525
46. S Rosenkranz 2004 TGF-beta1 and angiotensin networking in cardiac remodeling Cardiovasc Res 63 423 432 10.1016/j.cardiores.2004.04.030 1:CAS:528:DC%2BD2cXmtVWitbs%3D 15276467
47. M Asif J Egan S Vasan GN Jyothirmayi MR Masurekar S Lopez C Williams RL Torres D Wagle, et al. 2000 An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness Proc Natl Acad Sci USA 97 2809 2813 10.1073/pnas.040558497 1:CAS:528:DC%2BD3cXitVahsb4%3D 10706607
48. BP Shapiro TE Owan SF Mohammed DM Meyer LD Mills CG Schalkwijk MM Redfield 2008 Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines Circulation 118 1002 1010 10.1161/CIRCULATIONAHA.108.777326 1:CAS:528:DC%2BD1cXhtVejsL3L 18711013
49. AP Maggioni A Maseri C Fresco MG Franzosi F Mauri E Santoro G Tognoni 1993 Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) N Engl J Med 329 1442 1448 10.1056/NEJM199311113292002 1:STN:280:DyaK2c%2FhvFKitw%3D%3D 8413454
50. M St John Sutton MA Pfeffer L Moye T Plappert JL Rouleau G Lamas J Rouleau JO Parker MO Arnold B Sussex E Braunwald 1997 Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the survival and ventricular enlargement (SAVE) trial Circulation 96 3294 3299 1:STN:280:DyaK1c%2FlslWjtw%3D%3D 9396419
51. NG Frangogiannis 2008 The immune system and cardiac repair Pharmacol Res 58 88 111 10.1016/j.phrs.2008.06.007 1:CAS:528:DC%2BD1cXht1ejtLvO 18620057
52. M Bujak M Dobaczewski C Gonzalez-Quesada Y Xia T Leucker P Zymek V Veeranna AM Tager AD Luster NG Frangogiannis 2009 Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction Circ Res 105 973 983 10.1161/CIRCRESAHA.109. 199471 1:CAS:528:DC%2BD1MXhtlKrtrfO 19797174
53. M Dobaczewski C Gonzalez-Quesada NG Frangogiannis 2009 The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction J Mol Cell Cardiol 48 3 504 511 10.1016/j.yjmcc.2009.07. 015 19631653
54. BI Jugdutt 2003 Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108 1395 1403 10.1161/01.CIR.0000085658.98621.49 12975244
55. NG Frangogiannis 2006 The mechanistic basis of infarct healing Antioxid Redox Signal 8 1907 1939 10.1089/ars.2006.8.1907 1:CAS:528:DC%2BD28XhtVKntb7L 17034340
56. NG Frangogiannis G Ren O Dewald P Zymek S Haudek A Koerting K Winkelmann LH Michael J Lawler ML Entman 2005 The critical role of endogenous Thrombospondin (TSP)-1 in preventing expansion of healing myocardial infarcts Circulation 111 2935 2942 10.1161/CIRCULATIONAHA.104.510354 1:CAS:528: DC%2BD2MXksV2gsbw%3D 15927970
57. JN Cohn R Ferrari N Sharpe 2000 Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling J Am Coll Cardiol 35 569 582 10.1016/S0735-1097(99)00630-0 1:STN:280: DC%2BD3c7nvFajsw%3D%3D 10716457
58. M Bujak HJ Kweon K Chatila N Li G Taffet NG Frangogiannis 2008 Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction J Am Coll Cardiol 51 1384 1392 10.1016/j.jacc.2008.01.011 18387441
59. ME Swift AL Burns KL Gray LA DiPietro 2001 Age-related alterations in the inflammatory response to dermal injury J Invest Dermatol 117 1027 1035 10.1046/j.0022-202x.2001.01539.x 1:CAS:528:DC%2BD38XhtFOlsg%3D%3D 11710909
60. A Ding S Hwang R Schwab 1994 Effect of aging on murine macrophages. Diminished response to IFN-gamma for enhanced oxidative metabolism J Immunol 153 2146 2152 1:CAS:528:DyaK2cXlslOlsL8%3D 7519641
61. KC Flanders 2004 Smad3 as a mediator of the fibrotic response Int J Exp Pathol 85 47 64 10.1111/j.0959-9673.2004.00377.x 1:CAS:528:DC%2BD2cXlt1Wqsrg%3D 15154911
62. M Bujak G Ren HJ Kweon M Dobaczewski A Reddy G Taffet XF Wang NG Frangogiannis 2007 Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling Circulation 116 2127 2138 10.1161/CIRCULATIONAHA.107.704197 1:CAS:528:DC%2BD2sXht1elsrjN 17967775
63. K Shivakumar DE Dostal K Boheler KM Baker EG Lakatta 2003 Differential response of cardiac fibroblasts from young adult and senescent rats to ANG II Am J Physiol Heart Circ Physiol 284 H1454 H1459 1:CAS:528:DC%2BD3sXjtlyksrc%3D 12595286
64. TA Wynn 2008 Cellular and molecular mechanisms of fibrosis J Pathol 214 199 210 10.1002/path.2277 1:CAS:528:DC%2BD1cXhvFCkt7w%3D 18161745
65. BI Jugdutt A Jelani 2008 Aging and defective healing, adverse remodeling, and blunted post-conditioning in the reperfused wounded heart J Am Coll Cardiol 51 1399 1403 10.1016/j.jacc.2007.12.027 18387443
66. BI Jugdutt 2008 Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly Heart Fail Rev 13 439 452 10.1007/s10741-008-9090-1 18256930
67. PJ Simpson RF Todd 3rd JC Fantone JK Mickelson JD Griffin BR Lucchesi 1988 Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion J Clin Invest 81 624 629 10.1172/JCI113364 1:STN:280:DyaL1c7hs1Shsw%3D%3D 3339135
68. NG Frangogiannis 2006 Targeting the inflammatory response in healing myocardial infarcts Curr Med Chem 13 1877 1893 10.2174/092986706777585086 1:CAS:528:DC%2BD28Xms1Clt74%3D 16842199
69. Baran KW, Nguyen M, McKendall GR, Lambrew CT, Dykstra G, Palmeri ST, Gibbons RJ, Borzak S, Sobel BE, et al. (2001) Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation 104:2778-2783
70. D Cai M Xaymardan JM Holm J Zheng JR Kizer JM Edelberg 2003 Age-associated impairment in TNF-alpha cardioprotection from myocardial infarction Am J Physiol Heart Circ Physiol 285 H463 H469 1:CAS:528: DC%2BD3sXmsVahu7s%3D 12730063
71. M Xaymardan J Zheng I Duignan A Chin JM Holm VL Ballard JM Edelberg 2004 Senescent impairment in synergistic cytokine pathways that provide rapid cardioprotection in the rat heart J Exp Med 199 797 804 10.1084/jem.20031639 1:CAS:528:DC%2BD2cXisVagurg%3D 15007092
72. S Lehrke R Mazhari DJ Durand M Zheng D Bedja JM Zimmet KH Schuleri AS Chi KL Gabrielson JM Hare 2006 Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling Circ Res 99 553 560 10.1161/01.RES.0000238375.88582.d8 1:CAS:528:DC%2BD28XosFGnsb0%3D 16873716
73. ME Davis PC Hsieh AJ Grodzinsky RT Lee 2005 Custom design of the cardiac microenvironment with biomaterials Circ Res 97 8 15 10.1161/01.RES.0000173376. 39447.01 1:CAS:528:DC%2BD2MXntVartLY%3D 16002755